The Food and Drug Administration on Friday issued a warning on the popular arthritis drug Celebrex after studies showed that high doses of the drug increases the chance of heart attacks and strokes. This is after a similar drug, Vioxx, was removed from the market in September. Larry speaks with Dr. Sidney Wolfe, Director of Public Citizen’s health research group and Sam Kazman, General Counsel for Competitive Enterprise Institute about this latest warning and to discuss whether the FDA is approving drugs too quickly.
Audience-funded nonprofit news
Next Up:
0:00
0:00
-
Listen Listen